NeoGenomics reports 42% Test Volume Growth, 26% Revenue Growth and 22% Increase in Adjusted EBITDA for the Third Quarter 2012

[at noodls] – NEOGENOMICS, INC. PRESS RELEASE FOR IMMEDIATE RELEASE NeoGenomics reports 42% Test Volume Growth, 26% Revenue Growth and 22% Increase in Adjusted EBITDA for the Third Quarter 2012 Ft. Myers, Florida – … more

View todays social media effects on NEO

View the latest stocks trending across Twitter. Click to view dashboard